Research

A health economic model for evaluating a vaccine for the prevention of herpes zoster and post-herpetic neuralgia in the UK

Lee Moore¹, Vanessa Remy², Monique Martin¹^*, Maud Beillat² and Alistair McGuire³

¹ i3 Innovus, Uxbridge, UK

² Sanofi Pasteur MSD, Lyon, France

³ London School of Economics, London, UK

For all author emails, please log on.

Cost Effectiveness and Resource Allocation 2010, 8:7 doi:10.1186/1478-7547-8-7

Published: 30 April 2010

Additional file 1:

Vaccination Characteristics. Supplemental data.

Format: DOC Size: 29KB Download file

This file can be viewed with: Microsoft Word Viewer

Additional file 2:

Calculation of Utilities. Supplemental data.

Format: DOC Size: 41KB Download file

This file can be viewed with: Microsoft Word Viewer